Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Ketoconazole prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 187.2/KG in Q1 to USD 198.4/KG by Q2 as firmer imidazole and piperazine synthesis intermediate costs and recovering seborrhoeic dermatitis, tinea versicolor, and topical antifungal formulation procurement reversed the brief Q1 2026 pricing correction. Globally, the average rose from USD 137.7/KG in Q1 to USD 145.9/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 143-161/KG is expected, with continued firming on Middle East supply disruptions and growing antifungal dermatology, topical treatment, and steroidogenesis inhibition sector demand globally.
Ketoconazole is a synthetic imidazole antifungal produced by multi-step synthesis from piperazine and imidazole building blocks through nucleophilic substitution and coupling with 2-(2,4-dichlorophenyl)glycidyl ether, acetylation, and 1,3-dioxolane formation to yield the cis-1-[4-[4-[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxy]phenyl]piperazin-1-yl]ethan-1-one active molecule. The compound inhibits fungal CYP51 lanosterol 14-alpha-demethylase, disrupting ergosterol biosynthesis and compromising cell membrane integrity, while at higher concentrations also inhibiting mammalian steroidogenesis through CYP11A1, CYP11B1, and CYP17A1 inhibition. Due to hepatotoxicity risk from oral administration, ketoconazole is predominantly formulated as a topical agent. The largest pull comes from seborrhoeic dermatitis and dandruff treatment via two percent medicated shampoo formulations targeting Malassezia yeast on the scalp. Tinea versicolor, tinea pedis, and cutaneous candidiasis topical treatment and Cushing syndrome oral therapy add further demand. Androgen synthesis inhibition in prostate cancer salvage management and seborrhoeic scalp alopecia treatment linked to Malassezia yeast colonisation add further significant clinical demand. Imidazole and piperazine synthesis intermediate costs, seborrhoeic and tinea dermatology prescription volumes, and regional API production capacity all feed into the price.
The balance of supply and demand for Ketoconazole through H2 2026 leans moderately firm. Imidazole and piperazine synthesis intermediate costs firmed from Middle East chemical supply disruptions. Seborrhoeic dermatitis, tinea, and topical antifungal demand are growing with expanding dermatology access globally.
The main upside risk is synthesis intermediate cost increases alongside accelerating dermatology prescription volume growth. The main downside risk is Chinese and Indian API surplus and newer imidazole alternative competition maintaining price pressure below the forecast range.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 143 - 161 | Synthesis cost firming and topical antifungal/dermatology demand |
| United States | 149 - 167 | Steady seborrhoeic and tinea treatment demand holds firm |
| China | 103 - 121 | Large API capacity keeps it the most affordable |
| Germany | 183 - 201 | High synthesis and energy costs keep it the most expensive |
| India | 141 - 159 | Growing topical antifungal and export demand holds a firm middle |
US Ketoconazole prices averaged USD 160.9/KG in Q2 2026, up 6.0% from USD 151.8/KG in Q1 2026. Firmer synthesis intermediate costs and recovering seborrhoeic dermatitis and tinea topical procurement drove consistent buying through the quarter.
Why did the price of Ketoconazole change in Q2 2026 in the United States?
Firmer imidazole and piperazine synthesis intermediate costs raised the API production floor. Seborrhoeic dermatitis medicated shampoo, tinea versicolor topical cream, and Cushing syndrome procurement lifted buying. Cutaneous antifungal export demand provided additional support near USD 160.9/KG.
Chinese Ketoconazole prices averaged USD 111.5/KG in Q2 2026, up 6.0% from USD 105.2/KG in Q1 2026, the lowest among the tracked markets. Spring seborrhoeic and tinea export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.
Why did the price of Ketoconazole change in Q2 2026 in China?
Spring seborrhoeic dermatitis and tinea topical export and domestic procurement lifted buying. Firmer domestic imidazole and piperazine synthesis costs raised the floor. Large domestic API capacity kept China the most affordable source.
German Ketoconazole prices averaged USD 198.4/KG in Q2 2026, up 6.0% from USD 187.2/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European production economics. Recovering dermatology and topical antifungal demand maintained buying.
Why did the price of Ketoconazole change in Q2 2026 in Germany?
Higher imidazole and piperazine synthesis and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis chains. Recovering seborrhoeic, tinea, and Cushing syndrome procurement maintained buying near USD 198.4/KG.
Indian Ketoconazole prices averaged USD 153.4/KG in Q2 2026, up 6.0% from USD 144.7/KG in Q1 2026. Growing seborrhoeic dermatitis, tinea, and topical antifungal export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Ketoconazole change in Q2 2026 in India?
Growing seborrhoeic and tinea topical antifungal export and domestic procurement lifted buying. Firmer imidazole and piperazine import costs raised the production floor. Cushing syndrome and dermatology export demand provided additional support near USD 153.4/KG.
US prices averaged USD 151.8/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end seborrhoeic and tinea procurement moderation and soft synthesis costs eased the market before the Q2 spring dermatology recovery.
Why did the price of Ketoconazole change in Q1 2026 in the United States?
Post-year-end seborrhoeic dermatitis and tinea topical procurement moderation reduced buying urgency. Soft imidazole and piperazine synthesis costs eased the production floor. The market eased to USD 151.8/KG before the Q2 dermatology season recovery.
Chinese prices averaged USD 105.2/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-Lunar New Year seborrhoeic and topical antifungal procurement moderation and soft synthesis costs held the market near USD 105.2/KG.
Why did the price of Ketoconazole change in Q1 2026 in China?
Post-Lunar New Year seborrhoeic and topical antifungal procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 105.2/KG before the Q2 spring dermatology recovery.
German prices averaged USD 187.2/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end seborrhoeic and topical procurement moderation and soft synthesis and energy costs eased the European market near USD 187.2/KG.
Why did the price of Ketoconazole change in Q1 2026 in Germany?
Post-year-end seborrhoeic and tinea topical procurement moderation reduced urgency. Soft imidazole and piperazine synthesis and energy costs eased the floor. The market eased to USD 187.2/KG before the Q2 spring dermatology recovery.
Indian prices averaged USD 144.7/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-holiday seborrhoeic and topical procurement moderation and soft synthesis import costs held the market near USD 144.7/KG.
Why did the price of Ketoconazole change in Q1 2026 in India?
Post-holiday seborrhoeic and tinea topical procurement moderation reduced urgency. Soft imidazole and piperazine import costs eased the production floor. The market eased to USD 144.7/KG before the Q2 spring dermatology season recovery.
Global Ketoconazole prices firmed through Q3 and Q4 2025 on the dermatology treatment season, corrected in Q1 2026 on post-year-end moderation, then surged in Q2 2026. The average rose from USD 135.0/KG in Q2 2025 to USD 137.7/KG in Q3 and USD 140.5/KG in Q4, eased to USD 137.7/KG in Q1 2026, then surged to USD 145.9/KG in Q2 2026, a net gain of about 8.1% over the window. Imidazole synthesis cost cycles and seborrhoeic, tinea, and topical antifungal procurement drove the seasonal pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 145.9 | +6.0% | ↑ Rising |
| Q1 2026 | 137.7 | -2.0% | ↓ Falling |
| Q4 2025 | 140.5 | +2.0% | ↑ Rising |
| Q3 2025 | 137.7 | +2.0% | ↑ Rising |
| Q2 2025 | 135.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Ketoconazole prices firmed modestly through 2025 on consistent seborrhoeic dermatitis and tinea topical demand. The global average opened near USD 130.3/KG in Q1 2025 and closed at USD 140.5/KG in Q4, a full-year gain of about 7.8%. Imidazole synthesis cost firming and dermatology and topical antifungal procurement drove the upward trajectory.
US prices firmed from about USD 148.9/KG in Q1 2025 to USD 154.9/KG by Q4, a gain of 4.0%. Consistent seborrhoeic and tinea topical and Cushing syndrome demand supported the trend.
Chinese prices firmed from roughly USD 103.1/KG in Q1 2025 to USD 107.3/KG by Q4, a gain of 4.1%. Growing topical antifungal export and domestic demand drove the firming.
German prices firmed from about USD 183.5/KG in Q1 2025 to USD 191.0/KG by Q4, a gain of 4.1%. Consistent seborrhoeic, tinea, and Cushing syndrome demand and firm synthesis costs supported.
Indian prices firmed from roughly USD 142.0/KG in Q1 2025 to USD 147.7/KG by Q4, a gain of 4.0%. Growing topical antifungal and dermatology export demand drove consistent firming.
Expert Market Research: Your Source for Real-Time Ketoconazole Price Intelligence
Expert Market Research tracks Ketoconazole prices continuously across every major producing and consuming region. The team traces causation through imidazole and piperazine synthesis intermediate economics, seborrhoeic dermatitis and topical antifungal prescription cycles, and regional API production capacity. Contact Expert Market Research today for Ketoconazole pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Seborrhoeic dermatitis and dandruff treatment via two percent ketoconazole medicated shampoo formulations delivering scalp antifungal and anti-inflammatory effects against Malassezia yeast takes the largest topical market share. Tinea versicolor, tinea pedis, and cutaneous candidiasis topical cream and solution treatment, and Cushing syndrome adrenal steroidogenesis inhibition also consume significant volumes globally.
The Q2 2026 average was USD 160.9/KG in the United States, USD 111.5/KG in China, USD 198.4/KG in Germany, and USD 153.4/KG in India. Germany remains the highest-priced market.
The global average rose from USD 137.7/KG in Q1 to about USD 145.9/KG in Q2, a gain of around 6.0%. Recovering seborrhoeic and tinea demand and firmer synthesis costs drove the H1 recovery from the Q1 correction.
Post-year-end seborrhoeic dermatitis and topical antifungal procurement moderation reduced buying urgency. Soft imidazole and piperazine synthesis costs eased the production floor before the Q2 spring dermatology season recovery.
The global average is expected in the USD 143 to 161/KG range for H2 2026, with continued firming as synthesis costs stay elevated and seborrhoeic, tinea, and topical antifungal demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on dermatology and topical antifungal demand, and China prices lowest on domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to imidazole and piperazine synthesis intermediate costs, seborrhoeic dermatitis and tinea prescribing cycles, and dermatology treatment access expansion. Synthesis precursor prices and dermatology prescription data are key signals.
China and India hold the largest ketoconazole API synthesis capacity. Any imidazole or piperazine synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time topical antifungal and dermatology formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor seborrhoeic and tinea prescribing volumes as key demand signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.